You are here: Industry Insights > Biopharmaceutical

News List

Analysis of 39 New Biological Drugs Marketed in the World in 2018 PharmaSources/Xuanyao
February 01, 2019
21st century is the century of life sciences. Currently, more than half of members of the United States National Academy of Sciences engage in the life science field; more than half of the U.S. Federal Government’s budget for scientific research is used f
Sartorius Stedim Biotech Offers Services for Characterization of New Biological Entities (NBE) b3cnewswire
January 24, 2019
Sartorius Stedim Biotech (SSB), a leading international supplier for the biopharmaceutical industry, announced the launch of services for new biological entities....
China’s Antengene raises $120m to boost drug development pharmaceutical-technology
January 03, 2019
Chinese biopharmaceutical firm Antengene has raised $120m in a series B funding round led by Boyu Capital and FountainVest to support the development and commercialisation of new therapeutics.
Lupin in partnership with AbbVie en-cphi.cn
December 26, 2018
To develop and commercialise a novel oncology drug to treat haematological cancers
Orchard Therapeutics and SIRION Biotech Announce Licensing Agreement to Enhance Gene Therapy Manufacturing Efficiency b3cnewswire
December 17, 2018
Orchard Therapeutics (NASDAQ: ORTX), a leading commercial-stage biopharmaceutical company dedicated to transforming the lives of patients with......
Ablexis Announces Licensing Agreement with Allogene Therapeutics americanpharmaceuticalreview
December 10, 2018
Ablexis, LLC, a biopharmaceutical company focused on licensing its AlivaMab Mouse technology for antibody drug discovery, has announced a license agreement....
EUSA Pharma Appoints President of US Operations americanpharmaceuticalreview
December 06, 2018
EUSA Pharma, a global biopharmaceutical company with a focus on oncology and rare disease, has announced the appointment of Jeffrey S. Hackman as President.....
Open Health merges with med comms services provider Peloton pharmaphorum
December 05, 2018
UK-based Open Health Communications has merged with Peloton Advantage to create a global healthcare communications and market access group.
Athenex Announces License Agreement with PharmaEssentia for Oradoxel (Oral Formulation of Docetaxel) in Several Areas in Asia pharmafocusasia
December 03, 2018
Athenex, Inc., a global biopharmaceutical company dedicated to the research of new therapies for cancer and related diseases, Development and commercialization......
Immune Regulation Announces Positive Results from Phase 1 Clinical Trial of PIN201104 b3cnewswire
November 26, 2018
Study C1104-001 was a First Time in Human, randomised, double blind, placebo controlled, parallel group study in healthy volunteers and patients with asthma to assess the safety, tolerability and pharmacokinetics of single ascending and repeat doses of ‘1

Previous page 1 2 3 4 5 6 7 Next page